Notice of Intent to Publish a Funding Opportunity Announcement for Precision Medicine for Type 1 Diabetic Nephropathy (U01 Clinical Trial Not Allowed)
ID: 356545Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356545
Timeline
    Description

    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for a cooperative agreement aimed at advancing research on Type 1 Diabetic nephropathy (T1D). This initiative seeks applications from Recruitment Sites (RS) to enroll adult and pediatric patients with T1D, particularly those at high risk for diabetic nephropathy, into a longitudinal cohort study, which will include protocol-based kidney biopsies. The research will leverage existing resources from the Kidney Precision Medicine Project (KPMP) to create a Kidney Tissue Atlas, identify disease subgroups, and explore novel therapeutic targets. The estimated total program funding for this opportunity is $1.3 million, with the NOFO expected to be published in fall 2024 and applications due in late fall 2024. Interested applicants are encouraged to reach out to the NIDDK contacts provided in the announcement for further information.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Similar Opportunities
    Kidney Precision Medicine Project Recruitment Sites
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Kidney Precision Medicine Project (KPMP) Recruitment Sites through a cooperative agreement. This initiative aims to continue the KPMP, which focuses on collecting and analyzing human kidney biopsy tissue to uncover molecular pathways related to Chronic Kidney Diseases (CKDs) and Acute Kidney Injuries (AKIs), with an emphasis on enhancing participant recruitment and tissue interrogation. The program anticipates awarding approximately $4 million across seven grants, with applications expected to be submitted by September 15, 2026, and awards anticipated to be made by June 1, 2027. Interested applicants can reach out to Debbie S. Gipson at Debbie.Gipson@nih.gov or call 301-480-2268 for further information.
    Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Kidney Precision Medicine Project (KPMP) - Tissue Interrogation Sites (TIS) through a cooperative agreement, aimed at analyzing human kidney tissue. The primary objective is to collaborate with various sites to obtain and evaluate kidney biopsies from participants suffering from acute kidney injury (AKI) or chronic kidney disease (CKD), ultimately creating a Kidney Tissue Atlas and identifying critical disease subgroups and therapeutic targets. This initiative is crucial for advancing kidney disease research and developing novel therapies, with an estimated total program funding of $6 million and an expected seven awards to be made. Interested applicants can reach out to Debbie S. Gipson at Debbie.Gipson@nih.gov or by phone at 301-480-2268, with applications due by October 5, 2026, and project start anticipated on July 1, 2027.
    Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed), aimed at enrolling participants with acute kidney injury (AKI) and/or chronic kidney disease (CKD) into a longitudinal cohort study. The selected recruitment sites will collaborate with various entities to conduct protocol-based kidney biopsies, create a Kidney Tissue Atlas, and identify critical disease subgroups and therapeutic targets. This initiative is crucial for advancing kidney disease research and developing novel therapies, with an estimated total program funding of $4 million and an expected seven awards to be made. Interested applicants can reach out to Debbie S. Gipson, MS, MD at Debbie.Gipson@nih.gov or call 301-480-2268 for further information, with applications due by October 5, 2026, and project start anticipated on July 1, 2027.
    Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for collaborative research projects focused on type 1 diabetes, specifically utilizing biosamples and data from established clinical studies. The objective is to advance the understanding of the disease's etiology and pathogenesis, with funding available for studies that aim to explore disease mechanisms, delay onset, and improve prevention strategies. A total of $5.5 million is committed for up to four awards in Fiscal Years 2026 and 2027, with application deadlines beginning on May 26, 2025, and a final submission date of March 9, 2026. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Kidney Precision Medicine Project Tissue Interrogation Sites
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Kidney Precision Medicine Project (KPMP) Tissue Interrogation Sites through a cooperative agreement. This initiative aims to continue the KPMP, which focuses on the ethical collection and analysis of human kidney biopsy tissue to uncover molecular pathways related to Chronic Kidney Diseases (CKDs) and Acute Kidney Injuries (AKIs). The project is significant for advancing kidney disease research and enhancing participant recruitment, with an estimated total funding of $6 million to support up to 14 awards for recruitment and tissue interrogation sites. Interested applicants can reach out to Debbie S. Gipson at Debbie.Gipson@nih.gov or call 301-480-2268 for further information, with proposals due by October 5, 2026, and project start anticipated on July 1, 2027.
    Kidney Precision Medicine Project Central Hub
    National Institutes of Health
    The National Institutes of Health (NIH) is seeking applications for the Kidney Precision Medicine Project Central Hub through a cooperative agreement aimed at advancing research in chronic kidney diseases (CKDs) and acute kidney injuries (AKIs). This initiative, which builds on the existing Kidney Precision Medicine Project (KPMP) established in FY2017, aims to enhance participant recruitment and tissue interrogation, with a focus on discovering novel molecular pathways related to kidney health. The total estimated funding for this opportunity is $5 million, with one award anticipated, and interested applicants can reach out to Debbie S. Gipson at Debbie.Gipson@nih.gov or by phone at 301-480-2268 for further information. Key deadlines include an estimated synopsis post date of July 5, 2026, and a close date of October 5, 2026, with the project expected to commence on July 1, 2027.
    Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed), aimed at supporting the KPMP cohort through the collection and de-identification of clinical data and samples. The project seeks to establish a Central Hub that will collaborate with various sites to evaluate kidney biopsies from participants with acute kidney injury or chronic kidney disease, ultimately creating a Kidney Tissue Atlas and identifying critical components for novel therapies. This cooperative agreement has an estimated total funding of $5 million, with one award expected, and applications are due by October 5, 2026. For further inquiries, interested applicants can contact Debbie S. Gipson at Debbie.Gipson@nih.gov or by phone at 301-480-2268.
    Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium through a cooperative agreement. This initiative aims to advance research on cardiovascular disease in individuals with type 1 diabetes by soliciting applications for discovery and mechanistic studies, leveraging the resources of the existing CARE-T1D consortium formed in 2024. The program is particularly focused on hypothesis-driven research utilizing multi-omics and molecular approaches, encouraging collaboration among experts in related fields such as type 2 diabetes and atherosclerosis. The estimated total funding for this program is $4.5 million, with approximately eight awards expected to be made. Interested applicants can reach out to Dr. Chandima Nishadi De Abrew Rajapakse at Chandima.rajapakse@nih.gov or by phone at 240-429-5197. The application process is set to open with a synopsis posting on April 1, 2026, and will close on July 1, 2026, with awards anticipated by March 1, 2027.
    NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for investigator-initiated, high-risk multi-center clinical trials through the Notice of Funding Opportunity (NOFO) PA-25-147. This cooperative agreement (U01) aims to support innovative studies that address critical health issues related to diabetes, digestive diseases, and kidney conditions, requiring proposals to be hypothesis-driven and operationally classified as high-risk. The program emphasizes the importance of diverse perspectives in research and mandates that planning activities be completed prior to application submission. Interested applicants should note that the application period opens on January 3, 2025, with a submission deadline of November 5, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Diabetes Research Centers (P30 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) for Diabetes Research Centers (P30 Clinical Trial Optional), aimed at enhancing research collaboration and innovation in diabetes and related metabolic disorders. This initiative seeks to establish a community of preclinical and clinical researchers, providing access to specialized resources and a Pilot and Feasibility Program to foster significant advancements beyond individual project capabilities. With an estimated total program funding of $18.2 million and an award ceiling of $1 million, the NIH anticipates making approximately seven awards, encouraging applications from a diverse range of eligible entities, including non-domestic institutions and community-based organizations. Interested parties should prepare for the application process, as the estimated synopsis post date is July 30, 2025, with applications expected to be solicited by March 11, 2026, and awards anticipated by December 30, 2026. For further inquiries, contact Dr. Christopher J. Lynch at lynchcj@nih.gov or call 301-325-4232.